Description: Midatech Pharma Plc engages in the discovery and development of pharmaceutical products in the field of nanomedicine. It develops therapeutic products to enhance the delivery of medicines in diseases, which include diabetes and neurological/ophthalmologic conditions, as well as cancers, such as liver and pancreatic, ovarian, and brain. The company was founded in 2000 and is based in Abingdon, the United Kingdom.
Home Page: www.midatechpharma.com
MTP Technical Analysis
1 Caspian Point
Cardiff,
CF10 4DQ
United Kingdom
Phone:
44 29 2048 0180
Officers
| Name | Title |
|---|---|
| Mr. Stephen A. Stamp | CEO, CFO, Company Sec. & Director |
| Dr. Dmitry Zamoryakhin M.D. | Chief Scientific Officer |
| Dr. Daniel Palmer MBA, Ph.D. | VP of Technology |
| Dr. Tim Sparey Ph.D. | Chief Bus. Officer |
| Mr. Justin Barry BSc (Hons.), MBIOL, CBIOL, QP | Head of Manufacturing |
| Mr. Vincent Holmes | VP & Head of Clinical Operations |
| Mr. David Benharris | Pres of Midatech Pharma US Inc |
| Ms. Fiona Sharp | Group Financial Controller |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.6504 |
| Price-to-Sales TTM: | 5.0695 |
| IPO Date: | 2015-12-07 |
| Fiscal Year End: | December |
| Full Time Employees: | 20 |